Matches in SemOpenAlex for { <https://semopenalex.org/work/W2052220912> ?p ?o ?g. }
- W2052220912 endingPage "247" @default.
- W2052220912 startingPage "241" @default.
- W2052220912 abstract "To assess the incidence of postneonatal epilepsy in term infants treated with antiepileptic drugs for neonatal seizure discharges that were detected with amplitude-integrated electroencephalography (aEEG), 206 term infants were monitored using this modality. They received antiepileptic drugs for clinical as well as subclinical neonatal seizures. Follow-up data were analyzed for the development of postneonatal epilepsy and for their neurodevelopmental outcome, assessed at 3, 9, 18 months, and 3 and 5 years of age. A total of 169 (82%) neonates received two or more antiepileptic drugs. Overall mortality was 39% (n = 80). Forty-one of the 126 survivors (33%) were abnormal at follow-up, and 12 of them developed postneonatal epilepsy (9.4%). Eighty-four children survived after hypoxic-ischemic encephalopathy grade II (n = 92), and 6 (7%) developed postneonatal epilepsy. In this subgroup, no postneonatal epilepsy was observed if seizures were controlled within 48 hours after birth and when not more than two antiepileptic drugs were required. Twenty-four children survived after an intracranial hemorrhage (n = 28), and only 1 (4%) developed postneonatal epilepsy. Eleven children survived after perinatal arterial stroke (n = 13), and 2 (18%) developed postneonatal epilepsy. In conclusion, the incidence of postneonatal epilepsy after treatment of clinical and subclinical neonatal seizures detected with continuous amplitude-integrated electroencephalography was 9.4%; This figure is lower than previously reported in children who only received treatment for clinical seizures. To assess the incidence of postneonatal epilepsy in term infants treated with antiepileptic drugs for neonatal seizure discharges that were detected with amplitude-integrated electroencephalography (aEEG), 206 term infants were monitored using this modality. They received antiepileptic drugs for clinical as well as subclinical neonatal seizures. Follow-up data were analyzed for the development of postneonatal epilepsy and for their neurodevelopmental outcome, assessed at 3, 9, 18 months, and 3 and 5 years of age. A total of 169 (82%) neonates received two or more antiepileptic drugs. Overall mortality was 39% (n = 80). Forty-one of the 126 survivors (33%) were abnormal at follow-up, and 12 of them developed postneonatal epilepsy (9.4%). Eighty-four children survived after hypoxic-ischemic encephalopathy grade II (n = 92), and 6 (7%) developed postneonatal epilepsy. In this subgroup, no postneonatal epilepsy was observed if seizures were controlled within 48 hours after birth and when not more than two antiepileptic drugs were required. Twenty-four children survived after an intracranial hemorrhage (n = 28), and only 1 (4%) developed postneonatal epilepsy. Eleven children survived after perinatal arterial stroke (n = 13), and 2 (18%) developed postneonatal epilepsy. In conclusion, the incidence of postneonatal epilepsy after treatment of clinical and subclinical neonatal seizures detected with continuous amplitude-integrated electroencephalography was 9.4%; This figure is lower than previously reported in children who only received treatment for clinical seizures." @default.
- W2052220912 created "2016-06-24" @default.
- W2052220912 creator A5015965615 @default.
- W2052220912 creator A5025399359 @default.
- W2052220912 creator A5038391182 @default.
- W2052220912 creator A5082486070 @default.
- W2052220912 creator A5091885878 @default.
- W2052220912 date "2005-04-01" @default.
- W2052220912 modified "2023-10-04" @default.
- W2052220912 title "Postneonatal epilepsy following amplitude-integrated EEG-detected neonatal seizures" @default.
- W2052220912 cites W1970281868 @default.
- W2052220912 cites W1983602995 @default.
- W2052220912 cites W1991825474 @default.
- W2052220912 cites W1994842806 @default.
- W2052220912 cites W2000584049 @default.
- W2052220912 cites W2002369917 @default.
- W2052220912 cites W2006059271 @default.
- W2052220912 cites W2006245334 @default.
- W2052220912 cites W2008434522 @default.
- W2052220912 cites W2009063079 @default.
- W2052220912 cites W2011065059 @default.
- W2052220912 cites W2016619395 @default.
- W2052220912 cites W2021926195 @default.
- W2052220912 cites W2031118854 @default.
- W2052220912 cites W2034709361 @default.
- W2052220912 cites W2044976974 @default.
- W2052220912 cites W2047430582 @default.
- W2052220912 cites W2054156009 @default.
- W2052220912 cites W2054601863 @default.
- W2052220912 cites W2058504486 @default.
- W2052220912 cites W2062373527 @default.
- W2052220912 cites W2066676839 @default.
- W2052220912 cites W2070761736 @default.
- W2052220912 cites W2072095562 @default.
- W2052220912 cites W2074973858 @default.
- W2052220912 cites W2082995148 @default.
- W2052220912 cites W2092959372 @default.
- W2052220912 cites W2132662664 @default.
- W2052220912 cites W2133369864 @default.
- W2052220912 cites W2150258792 @default.
- W2052220912 cites W2160632730 @default.
- W2052220912 cites W2163414525 @default.
- W2052220912 cites W2164150771 @default.
- W2052220912 cites W2171470800 @default.
- W2052220912 cites W2322833765 @default.
- W2052220912 cites W4235217257 @default.
- W2052220912 doi "https://doi.org/10.1016/j.pediatrneurol.2004.11.005" @default.
- W2052220912 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15797180" @default.
- W2052220912 hasPublicationYear "2005" @default.
- W2052220912 type Work @default.
- W2052220912 sameAs 2052220912 @default.
- W2052220912 citedByCount "102" @default.
- W2052220912 countsByYear W20522209122012 @default.
- W2052220912 countsByYear W20522209122013 @default.
- W2052220912 countsByYear W20522209122014 @default.
- W2052220912 countsByYear W20522209122015 @default.
- W2052220912 countsByYear W20522209122016 @default.
- W2052220912 countsByYear W20522209122017 @default.
- W2052220912 countsByYear W20522209122018 @default.
- W2052220912 countsByYear W20522209122019 @default.
- W2052220912 countsByYear W20522209122020 @default.
- W2052220912 countsByYear W20522209122021 @default.
- W2052220912 countsByYear W20522209122022 @default.
- W2052220912 countsByYear W20522209122023 @default.
- W2052220912 crossrefType "journal-article" @default.
- W2052220912 hasAuthorship W2052220912A5015965615 @default.
- W2052220912 hasAuthorship W2052220912A5025399359 @default.
- W2052220912 hasAuthorship W2052220912A5038391182 @default.
- W2052220912 hasAuthorship W2052220912A5082486070 @default.
- W2052220912 hasAuthorship W2052220912A5091885878 @default.
- W2052220912 hasConcept C113280763 @default.
- W2052220912 hasConcept C118552586 @default.
- W2052220912 hasConcept C120665830 @default.
- W2052220912 hasConcept C121332964 @default.
- W2052220912 hasConcept C126322002 @default.
- W2052220912 hasConcept C187212893 @default.
- W2052220912 hasConcept C2778186239 @default.
- W2052220912 hasConcept C2778621155 @default.
- W2052220912 hasConcept C2780208886 @default.
- W2052220912 hasConcept C42219234 @default.
- W2052220912 hasConcept C522805319 @default.
- W2052220912 hasConcept C61511704 @default.
- W2052220912 hasConcept C71924100 @default.
- W2052220912 hasConceptScore W2052220912C113280763 @default.
- W2052220912 hasConceptScore W2052220912C118552586 @default.
- W2052220912 hasConceptScore W2052220912C120665830 @default.
- W2052220912 hasConceptScore W2052220912C121332964 @default.
- W2052220912 hasConceptScore W2052220912C126322002 @default.
- W2052220912 hasConceptScore W2052220912C187212893 @default.
- W2052220912 hasConceptScore W2052220912C2778186239 @default.
- W2052220912 hasConceptScore W2052220912C2778621155 @default.
- W2052220912 hasConceptScore W2052220912C2780208886 @default.
- W2052220912 hasConceptScore W2052220912C42219234 @default.
- W2052220912 hasConceptScore W2052220912C522805319 @default.
- W2052220912 hasConceptScore W2052220912C61511704 @default.
- W2052220912 hasConceptScore W2052220912C71924100 @default.
- W2052220912 hasIssue "4" @default.
- W2052220912 hasLocation W20522209121 @default.